Linde India Delivers Strong Q3 Growth in Gases & Projects
LINDEINDIA Linde India Ltd has delivered a robust Q3 CY26 performance with strong revenue growth and margin expansion, supported by industrial gas demand and project execution. ⚗️ Key Financial Highlights (Q3 CY26, ended Sept 30 2026) Metric Q3 CY26 YoY Change Notes Revenue ₹780 crore ↑ 11.4% Higher volumes in merchant gases and healthcare EBITDA ₹210 crore ↑ 14.8% Improved efficiency and cost control Net Profit ₹122 crore ↑ 16.2% Strong operating leverage EPS ₹11.85 ↑ 15.7% Reflects steady earnings momentum 🏭 Segment Performance Gases & Related Products: Revenue ↑ 10.9% YoY; growth driven by steel, automotive, and healthcare clients. Project Engineering: Revenue ↑ 13.2% YoY; execution of large air‑separation units and cryogenic projects. Healthcare Oxygen: Continued strong demand from hospitals and medical facilities. ⚙️ Strategic Updates New Projects: Commissioned a new air‑separation unit in Jharkhand and expanded capacity in Gujarat. Sustainability: Increased green hydrogen pilot production and solar energy usage at plants. Partnerships: Collaborating with steel majors for long‑term gas supply contracts. Innovation: Investing in cryogenic storage and liquefaction technology for industrial clients. 📈 Market Performance Share Price: ₹6,420 on NSE (↑ 4.8% post‑results). Market Cap: ₹55,000 crore. Analyst View: Brokerages maintain “Buy” rating with target ₹6,800–₹7,000 on steady industrial gas demand. ⚠️ Risks & Outlook Risks: Energy cost fluctuations and project execution delays. Outlook: Strong industrial and medical gas demand expected to drive growth; management targets double‑digit revenue growth for CY27.




















